Ovarian Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Ovarian Cancer, including details on symptoms, causes, treatment, information.

Volume 3 (2006), Issue 11 (November)

1. Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer.
   J Natl Cancer Inst, 98(21): 1558-70. [Abstract] [Full-text]
2. Ovarian cancer screening in women with a family history of breast or ovarian cancer.
   Obstet Gynecol, 108(5): 1176-84. [Abstract] [Full-text]
3. Evaluation of adnexal masses with three-dimensional ultrasonography.
   Obstet Gynecol, 108(5): 1167-75. [Abstract] [Full-text]
4. HLA-class II haplotype associations with ovarian cancer.
   Int J Cancer, 119(12): 2980-5. [Abstract] [Full-text]
5. Use of hormone replacement therapy before and after ovarian cancer diagnosis and ovarian cancer survival.
   Int J Cancer, 119(12): 2907-15. [Abstract] [Full-text]
6. Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients.
   Int J Cancer, 119(12): 2832-9. [Abstract] [Full-text]
7. Interferon beta adenoviral gene therapy in a patient with ovarian cancer.
   Nat Clin Pract Oncol, 3(11): 633-9. [Abstract] [Full-text]
8. Ovarian cancer: a focus on management of recurrent disease.
   Nat Clin Pract Oncol, 3(11): 604-11. [Abstract] [Full-text]
9. Alterations of the tumor suppressor gene ARLTS1 in ovarian cancer.
   Cancer Res, 66(21): 10287-91. [Abstract] [Full-text]
10. Progesterone receptor isoforms as a prognostic marker in human endometrial carcinoma.
    Cancer Sci, 97(12): 1308-14. [Abstract] [Full-text]
11. Characteristic expression of globotriaosyl ceramide in human ovarian carcinoma-derived cells with anticancer drug resistance.
    Cancer Sci, 97(12): 1321-6. [Abstract] [Full-text]
12. Mechanisms of transcoelomic metastasis in ovarian cancer.
    Lancet Oncol, 7(11): 925-34. [Abstract] [Full-text]
13. Expression of multiple human endogenous retrovirus surface envelope proteins in ovarian cancer.
    Int J Cancer, 120(1): 81-90. [Abstract] [Full-text]
14. Analysis of chromosomal changes in serous ovarian carcinoma using high-resolution array comparative genomic hybridization: Potential predictive markers of chemoresistant disease.
    Genes Chromosomes Cancer, 46(1): 1-9. [Abstract] [Full-text]
15. Survival benefits with diverse chemotherapy regimens for ovarian cancer: meta-analysis of multiple treatments.
    J Natl Cancer Inst, 98(22): 1655-63. [Abstract] [Full-text]
16. Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9.
    Cancer Res, 66(22): 10902-10. [Abstract] [Full-text]
17. Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors.
    Cancer Res, 66(22): 10795-804. [Abstract] [Full-text]
18. New potential ligand-receptor signaling loops in ovarian cancer identified in multiple gene expression studies.
    Cancer Res, 66(22): 10709-19. [Abstract] [Full-text]
19. Nonbacterial thrombotic endocarditis with recurrent embolic events as manifestation of ovarian neoplasm.
    J Gen Intern Med, 21(12): C12-5. [Abstract] [Full-text]
20. Unusual fast-growing ovarian cystic teratoma during pregnancy presenting with intracystic fat "floating balls" appearance.
    Fertil Steril, 86(6): 1758-9. [Abstract] [Full-text]
21. The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis.
    Cancer, 107(11): 2730-40. [Abstract] [Full-text]
22. In vivo tracking of macrophage activated killer cells to sites of metastatic ovarian carcinoma.
    Cancer Immunol Immunother, 56(2): 155-63. [Abstract] [Full-text]
23. Role of lymphadenectomy in the management of grossly apparent advanced stage epithelial ovarian cancer.
    Am J Obstet Gynecol, 195(6): 1862-8. [Abstract] [Full-text]
24. Age-dependent bimodal GDNF regulation during ovarian tumorigenesis in follitropin receptor mutant mice.
    Biochem Biophys Res Commun, 351(2): 507-13. [Abstract] [Full-text]

© 2004-2008 Ovarian Cancer Research Today. All Rights Reserved.